Beligas Pharma Acro Trestolone Ment — Research Summary
Trestolone acetate, commonly known as MENT (7α-methyl-19-nortestosterone acetate), is a synthetic anabolic-androgenic steroid developed for research applications. This Beligas Pharma formulation delivers 50mg/ml concentration in injectable form, allowing researchers at Stroid UK Shop to investigate its unique molecular properties. Unlike conventional testosterone derivatives, trestolone acetate demonstrates exceptional androgenic potency in preclinical models while maintaining oral bioavailability when administered in research studies. The acetate ester provides controlled release kinetics in laboratory environments, making it valuable for examining steroid pharmacology and receptor binding mechanisms.
Research Applications
Scientific literature indicates trestolone acetate exhibits approximately 10-fold greater androgenic activity than testosterone in animal models, making it a subject of intense research interest. Investigators studying androgen receptor modulation often examine this compound’s selective tissue effects and metabolic pathways. Research applications include investigating steroidogenesis mechanisms, examining androgen-responsive gene expression patterns, and evaluating novel contraceptive approaches in male subjects. Studies have explored its effects on bone density markers, muscle protein synthesis pathways, and hypothalamic-pituitary-gonadal axis suppression. Researchers working with steroid injection compounds often compare trestolone’s receptor selectivity against traditional androgens. The compound’s resistance to 5α-reductase enzyme activity provides unique research opportunities for understanding tissue-specific androgen metabolism. Additionally, investigations into its progestogenic activity and interaction with progesterone receptors contribute to broader endocrine research programs.
Specifications
| Parameter | Value |
|---|---|
| Chemical Name | 7α-Methyl-19-nortestosterone acetate |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Concentration | 50mg/ml |
| Form | Injectable solution |
| Manufacturer | Beligas Pharma |
| Purity | Research grade |
| Storage | Room temperature, protect from light |
| Solvent System | Pharmaceutical grade carrier oil |
Researchers studying advanced compounds may also examine related categories including SARMs research chemicals and peptide research compounds for comparative molecular studies.
Research Compliance
This trestolone acetate preparation is supplied exclusively for in-vitro research purposes and laboratory studies. Not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with local regulations governing research chemical handling and maintain appropriate laboratory safety protocols during investigations.
